Ticker
RLYBCompany Name
RALLYBIO CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 116K | 15.24% | $ 761K |
3/31/2025 | $ 124K | 14.62% | $ 848K |
12/31/2024 | $ 131K | 20.6% | $ 636K |
9/30/2024 | $ 137K | 22.91% | $ 598K |
6/30/2024 | $ 142K | 47.49% | $ 299K |
3/31/2024 | $ 146K | 0% | $ 0 |
12/31/2023 | $ 150K | 0% | $ 0 |
9/30/2023 | $ 153K | 0% | $ 0 |
6/30/2023 | $ 158K | 0% | $ 0 |
3/31/2023 | $ 164K | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor / Revenues
(=) DepAmor %
DepAmor % for RALLYBIO CORP is calculated as follows: DepAmor [ $ 62K ] / Revenues [ $ 0 ]
(=) DepAmor % [ 0% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.31K |
---|---|
min | -6.41% |
max | 22.52% |
average | 5.85% |
median | 4.22% |
std | 5.12% |